Agonists and Antagonists
- 1 imageAT-406 [orb181200]
[1071992-57-8]
597.31
C32H43N5O4
O=C1[C@H](CN(C(CC(C)C)=O)CC[C@H]2CC[C@@H](C(NC(C3C=CC=CC=3)C3C=CC=CC=3)=O)N21)NC([C@H](C)NC)=O
100 mg, 250 mg, 1000 mg -
- 1 imageAnamorelin [orb181194]
[249921-19-5]
546.70359
C31H42N6O3
[H][C@](CC1=CNC2=CC=CC=C21)(NC(C(C)(C)N)=O)C(N3CCC[C@@](C(N(C)N(C)C)=O)(CC4=CC=CC=C4)C3)=O
100 mg, 250 mg, 1000 mg -
- A-740003 [orb181189]
[861393-28-4]
474.57
C26H30N6O3
N#C/N=C(NC(NC(CC1=CC(OC)=C(C=C1)OC)=O)C(C)(C)C)NC2=CC=CC3=NC=CC=C23
100 mg, 250 mg, 1000 mg - 1 imageWZ 811 [orb181180]
[55778-02-4]
290.36
C18H18N4
C1=CC=NC(=C1)NCC2=CC=C(C=C2)CNC3=CC=CC=N3
10 mM * 1 mL in DMSO, 100 mg, 250 mg, 1000 mg -
- Tirofiban(L700462;MK383) [orb181173]
[144494-65-5]
440.6
C22H36N2O5S
C(O)(=O)[C@@H](CC1C=CC(OCCCCC2CCNCC2)=CC=1)NS(CCCC)(=O)=O
100 mg, 250 mg, 1000 mg - Imiloxan [orb181126]
[81167-16-0]
244.28904
C14H16N2O2
CCN1C=CN=C1CC2OC3=CC=CC=C3OC2
100 mg, 250 mg, 1000 mg - S1RA [orb181123]
[878141-96-9]
337.42
C20H23N3O2
CC1=CC(=NN1C2=CC3=CC=CC=C3C=C2)OCCN4CCOCC4
100 mg, 250 mg, 1000 mg - SB-408124 [orb181122]
[288150-92-5]
356.37
C19H18F2N4O
O=C(NC1=CC(C)=NC2=C(C=C(C=C21)F)F)NC3=CC=C(C=C3)N(C)C
100 mg, 250 mg, 1000 mg - Purmorphamine [orb181106]
[483367-10-8]
520.62
C31H32N6O2
C1CCC(CC1)N2C=NC3=C2N=C(N=C3NC4=CC=C(C=C4)N5CCOCC5)OC6=CC=CC7=CC=CC=C76
10 mM * 1 mL in DMSO, 100 mg, 250 mg, 1000 mg - 1 imageAM 281 [orb181102]
[202463-68-1]
557.21
C21H19Cl2IN4O2
O=C(C1=NN(C2=CC=C(Cl)C=C2Cl)C(C3=CC=C(I)C=C3)=C1C)NN4CCOCC4
10 mM * 1 mL in DMSO, 100 mg, 250 mg, 1000 mg -
